References
- Reveille J. D. The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 1998; 10: 187–200
- Pawlik A., Florczak M., Ostanek L., Brzosko M., Brzosko I., Gawronska‐Szklarz B. TNF‐308 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheum 2005; 34: 22–6
- Pawlik A., Wrzesniewska J., Florczak M., Gawronska‐Szklarz B., Herczynska M. IL‐6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheum 2005; 34: 109–13
- Hoffmann S. C., Stanley E. M., Darrin Cox E., Craighead N., DiMercurio B. S., Koziol D. E., et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti‐CD3/CD28‐stimulated peripheral blood lymphocytes. Transplantation 2001; 72: 1444–50
- McInnes I. B., Gracie J. A., Leung B. P., Wei X. Q., Liew F. Y. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 2000; 21: 312–15
- Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin‐18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423–74
- Xu D., Trajkovic V., Hunter D., Leung B. P., Schulz K., Gracie J. A., et al. IL‐18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur J Immunol 2000; 30: 3147–56
- Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin‐18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001; 12: 53–72
- Gracie J. A., Forsey R. J., Chan W. L., Gilmour A., Leung B. P., Greer M. R., et al. A proinflammatory role for IL‐18 in rheumatoid arthritis. J Clin Invest 1999; 104: 1337–9
- Bokarewa M., Hultgren O. Is interleukin‐18 useful for monitoring rheumatoid arthritis?. Scand J Rheumatol 2005; 34: 433–6
- Masui K., Tsutsui H., Nakanishi K. Pathophysiological roles for IL‐18 in inflammatory arthritis. Expert Opin Ther Targets 2003; 7: 701–24
- Kotake S., Nanke Y., Mogi M., Kawamoto M., Furuya T., Yago T., et al. IFN‐gamma‐producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur J Immunol 2005; 35: 3353–63
- Maalej A., Ben Hamad M., Rebai A., Teixeira V. H., Bahloul Z., Marzouk S., et al. Association of INFγ gene polymorphisms with rheumatoid arthritis in a Tunisian population. Scand J Rheumatol 2008; 27: 1–5
- Pawlik A., Kurzawski M., Czerny B., Gawronska‐Szklarz B., Drozdzik M., Herczynska M. Interleukin‐18 promoter polymorphism in patients with rheumatoid arthritis. Tissue Antigens 2006; 67: 415–8
- Felson D. T., Anderson J. J., Boers M., Bombardier C., Chernoff M., Fried B., et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993; 36: 729–40
- Gustincich S., Manfioletti G., Del Sal G., Schneider C., Carninci P. A fast method for high‐quality genomic DNA extraction from whole human blood. Biotechniques 1991; 11: 298–300; 302
- Kretowski A., Mironczuk K., Karpinska A., Bojaryn U., Kinalski M., Puchalski Z., et al. Interleukin‐18 promoter polymorphism in type 1 diabetes. Diabetes 2002; 51: 3347–9
- Kruse S., Kuehr J., Moseler M., Kopp M. V., Kurz T., Deichmann K. A., et al. Polymorphisms in the IL18 gene are associated with specific sensitization to common allergens and allergic rhinitis. J Allergy Clin Immunol 2003; 111: 117–22
- Terwilliger J., Ott J. Handbook of human genetic linkage. Johns Hopkins University Press, Baltimore 1994
- Giedraitis V., He B., Huang W. X., Hillert J. Cloning and mutation analysis of the human IL‐18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146–52
- Sivalingam S. P., Yoon K. H., Koh D. R., Fong K. Y. Single‐nucleotide polymorphisms of the interleukin‐18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue Antigens 2003; 62: 498–504
- Gracie J. A., Koyama N., Murdoch J., Field M., McGarry F., Crilly A., et al. Disease association of two distinct interleukin‐18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun 2005; 6: 211–16
- Rueda B., Gonzalez‐Gay M. A., Mataran L., Lopez‐Nevot M. A., Martin J. Interleukin‐18‐promoter polymorphisms are not relevant in rheumatoid arthritis. Tissue Antigens 2005; 65: 544–8
- Lee C. C., Lin W. Y., Wan L., Tsai Y., Lin Y. J., Tsai C. H., et al. Interleukin‐18 gene polymorphism, but not interleukin‐2 gene polymorphism, is associated with rheumatoid arthritis. Immunogenetics 2007; 59: 433–9